Key result
Five-gene peripheral transcript signature stratifies CHF patients into four immune clusters along a myeloid axis.
Why the study?
Immune alterations in chronic heart failure have been characterized mainly at the group level, leaving patient-level heterogeneity undefined. Whether peripheral blood transcriptomes resolve distinct immune states in CHF, and how those transcripts behave in tumors relevant to cardio-oncology, remained unclear.
Do peripheral blood transcriptomes resolve distinct immune states within chronic heart failure?
Observational (n=1,152)
Do peripheral blood transcriptomes resolve distinct immune states within chronic heart failure?
Peripheral blood transcriptomics reveals that immune status in chronic heart failure varies individually along a continuous lymphoid-to-myeloid axis driven by circulating immune cell composition.
Answers are grounded in this paper and cite their sources.
Immune heterogeneity in chronic heart failure cautions against uniform immunomodulation; leaves open validation of transcriptomic clusters for prognosis or therapy.
Background/Objectives: Immune alterations in chronic heart failure (CHF) have been characterized mainly at the group level, leaving heterogeneity between patients undefined. We asked whether peripheral blood transcriptomes resolve distinct immune states within CHF, and how the same transcripts behave in tumors relevant to cardio-oncology. Methods: Features were selected from publicly available peripheral blood transcriptomes (CHF = 944, normal = 11) by multiple network analyses and machine learning algorithms, and consensus clustering was applied within the CHF cohort. Clusters were characterized by enrichment analyses and by estimated immune cell composition and immune-related functional signatures. The coordinates separating the clusters were fixed and applied to an independent CHF cohort of 197 patients with measured blood count differentials. Immunohistochemical and overall survival data from public tumor cohorts were examined. Results: Five weakly correlated transcripts (CASP6, CAPNS1, BAK1, CASP4 and BAD) separated the 944 patients with CHF into four clusters placed on two nearly independent coordinates, the dominant one being the balance between lymphoid and myeloid programs. Patients at opposite ends of that axis differed in almost every immune measure and in opposite directions, from a lymphoid-enriched, effector-engaged state to a myeloid-skewed, lymphoid-depleted state. Cluster 1, the largest at 39.5%, lay near the cohort average. Enriched terms were largely shared, so the separation was carried by immune cell composition rather than pathway level divergence. In the independent cohort, the coordinates kept the same relation to measured lymphocyte, neutrophil and monocyte counts. In exploratory tumor analyses, the five transcripts did not keep a single direction outside blood, and their associations with overall survival differed between tumor types. Conclusions: Peripheral blood transcriptomes place patients with CHF along a continuous lymphoid-to-myeloid axis, carried mainly by circulating immune cell composition, on which the four clusters mark positions rather than separate states and which holds in an independent cohort. Immune status in CHF is a property of the individual patient rather than of the population.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) conducted an observational in Chronic heart failure (n=1,152). Peripheral blood transcriptomic profiling (CASP6, CAPNS1, BAK1, CASP4, BAD) vs. Normal controls and internal transcriptomic clusters was evaluated on Transcriptomic cluster stratification along a lymphoid-to-myeloid immune axis. Five peripheral blood transcripts stratified 944 CHF patients into 4 clusters along a lymphoid-to-myeloid axis, validated in an independent cohort of 197 patients.
Synapse has enriched 10 related papers. Consider them for comparative context: